arrow
B

Behnam Ebrahimi

University of Texas Health Science Center at San Antonio
H指数:17
被引数:1,082

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic optimization of LIPA targeting to induce endoplasmic reticulum stress and cell death in ovarian cancer

LIPA靶向诱导卵巢癌内质网应激和细胞死亡的治疗优化

2026-02-060
OAAI
EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling

EC359 通过抑制 LIFR 信号通路增强 Trametinib 在 Ras/Raf 驱动的卵巢癌中的疗效

2025-10-010
OAAI
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis
2024-05-243
OAAI
Pharmacological inhibition of the LIF-LIFR autocrine loop reveals vulnerability of ovarian cancer to ferroptosis
2024-03-220
PRE
Preclinical evaluation of ERX-208, a potent inducer of ER stress for the treatment of ovarian cancer
2024-03-220
PRE
Novel LIPA targeted therapy for treating ovarian cancer
2023-04-040
PRE
ERX-208 as a novel therapeutic for treating ovarian cancer by enhancing endoplasmic reticulum stress
2023-04-040
PRE
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER plus Breast Cancer
2022-08-118
OA
LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
2021-10-2917
OAAI
LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
2021-08-1621
OAAI